Literature DB >> 6863475

A unique growth factor in patients with acromegaloidism.

M W Ashcraft, P I Hartzband, A J Van Herle, N Bersch, D W Golde.   

Abstract

Acromegaloidism is a syndrome characterized by features of acromegaly without biochemical evidence of excessive GH or somatomedin production. We searched for a growth factor in the serum of patients with this syndrome. Growth-promoting activity was measured by determining the stimulatory effect of whole and fractionated serum on colony formation by human erythroid progenitors in vitro. Sera from five subjects with acromegaloidism gave a mean (+/- SEM) stimulated colony growth of 211 +/- 4.0 colonies, in contrast to normal sera which yielded a mean colony growth of 100 +/- 11.0 (n = 9; P less than 0.001). When serum was chromatographed on a Sephadex G-200 column, the maximal stimulation of colony growth was found in the fractions coinciding with the descending slope of the second protein peak. Based on gel filtration chromatography, the estimated molecular weight was 70,000 daltons. Epidermal growth factor, nerve growth factor, fibroblast growth factor, and platelet-derived growth factor resulted in no substantial stimulation of colony growth under the conditions used. Although the erythroid progenitor cells of a Laron dwarf were unresponsive to 200 ng/ml human GH, they were clearly stimulated by serum from a patient with acromegaloidism. The present study describes the presence of a heretofore unidentified growth factor in the serum of subjects with acromegaloidism. This factor also stimulated the erythroid precursor cells of a Laron dwarf whose cells were unresponsive to GH. The physiological role of this growth factor in normal man as well as its pathogenic role in subjects with acromegaloidism remain to be established.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863475     DOI: 10.1210/jcem-57-2-272

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Untreated hypopituitarism due to absence of the pituitary stalk with normal adult height: report of two cases.

Authors:  Leda Papastathopoulou; Marinella Tzanela; Vania Vlassopoulou; Dimitra Vassiliadi; Nikolaos Thalassinos
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Acromegaloidism with normal growth hormone secretion associated with X-tetrasomy.

Authors:  Paula Alvarez-Vázquez; Alberto Rivera; Irene Figueroa; Concepción Páramo; Ricardo V García-Mayor
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  Bone mineral density in survivors of childhood brain tumours.

Authors:  M Petraroli; E D'Alessio; E Ausili; A Barini; P Caradonna; R Riccardi; M Caldarelli; A Rossodivita
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

4.  Primary hypothyroidism presenting as pseudoacromegaly.

Authors:  K V S Hari Kumar; Altamash Shaikh; Irfan Anwar; P Prusty
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 5.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

6.  Excessive growth in a child with craniopharyngioma and growth hormone deficiency.

Authors:  J M Wit; A Schuitema-Dijkstra; S van Buul-Offers; F Opmeer; J L Van den Brande
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

7.  Acromegaloid facial appearance: case report and literature review.

Authors:  Adline Ghazi; Shikha Khosla; Kenneth Becker
Journal:  Case Rep Endocrinol       Date:  2013-02-28

8.  Anorexia nervosa associated with acromegaloid features, onset of acrocyanosis and Raynaud's phenomenon and worsening of chilblains.

Authors:  M H Rustin; J C Foreman; P M Dowd
Journal:  J R Soc Med       Date:  1990-08       Impact factor: 18.000

9.  Pseudoacromegaly Associated with Non-Functioning Pituitary Adenoma.

Authors:  Awatef Alotaibi; Ahmad Habib; Moutaz Osman; Khaled Alzahrani; Faisal Alzahrani
Journal:  Eur J Case Rep Intern Med       Date:  2020-10-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.